HIV
Linee Guida Italiane sull’utilizzo della Terapia Antiretrovirale e la gestione diagnostico-clinica delle persone con infezione da HIV-1 – SIMIT e Ministero della salute (2017)
https://www.salute.gov.it/imgs/C_17_pubblicazioni_2696_allegato.pdf
Linee Guida Italiane sull’utilizzo della Terapia Antiretrovirale e la gestione diagnostico-clinica delle persone con infezione da HIV-1 – SIMIT e Ministero della salute (2017)
https://www.eacsociety.org/media/guidelines-10.1_30032021_1.pdf]
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach – WHO (luglio 2017)
https://www.who.int/publications/i/item/9789240031593
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV – Departement of Health and Human service USA(2021)
https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf]
NICE guidelines (01/12/2016)
https://www.nice.org.uk/guidance/ng60
ANTIMICROBICI
NICE guidelines (2016)
https://www.nice.org.uk/guidance/qs121/resources/antimicrobial-stewardship-pdf-75545353537477
Linee Guida Ministero della Salute
WHO Global Strategy for Containment of Antimicrobial Resistance (2001)
https://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf
Report WHO antibiotici (2021)
WHO-2021-ANTIBACTERIAL-AGENTS.pdf
Linee Guida EMA sulla condizione degli studi su antibiotici (2022)
guideline-evaluation-medicinal-products-indicated-treatment-bacterial-infections-revision-3_en.pdf
Addendum Linee Guida EMA sulla condizione degli studi su antibiotici in pediatria (2022)
ANTIMICOTICI
Linee guida EMA (2010)
COVID
Farmaci utilizzabili per il trattamento della malattia COVID-19 AIFA
COVID-19 Treatment Guidelines of National Institutes of Health
https://www.covid19treatmentguidelines.nih.gov